Skip to main content
Erschienen in: Herz 1/2024

25.07.2023 | Original articles

The effect of high-power short-duration pulmonary vein isolation on PWPT—a predictor of paroxysmal atrial fibrillation

verfasst von: Meng Wang, Xiaochen Wang, Feng Gao, Pei Bao, Zheng Huang

Erschienen in: Herz | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

The P wave peak time (PWPT) is a predictor of paroxysmal atrial fibrillation (PAF). High-power short-duration ablation has been associated with improved durability of circumferential pulmonary vein electrical isolation (PVI). We investigated the effect of high-power short-duration PVI on PWPT in patients with PAF.

Methods

Out of 111 patients with PAF, 91 received radiofrequency ablation (ablation group) and 20 received medication treatment (control group). A VIZIGO sheath and an STSF catheter (Biosense Webster, CA, USA) were used together for high-power short-duration circumferential PVI at ablation index values of 500 and 400 for the anterior and posterior walls, respectively. The patients were followed up for 12 months.

Results

The preoperative PWPT in the ablation group was similar to that in the control group: PWPT II = 54.38 ± 6.18 ms vs. 54.35 ± 6.12 ms (p > 0.05), PWPT V1 = 54.19 ± 6.21 ms vs. 54.31 ± 6.08 ms (p > 0.05), respectively. Circumferential PVI was achieved for all patients in the ablation group during the operation. At the 12-month follow-up, there were seven cases of AF recurrence. The PWPT in the ablation group 12 months postoperatively was shorter than the preoperative value: PWPT II = 49.39 ± 7.11 ms vs. 54.38 ± 6.18 ms (p < 0.001), PWPT V1 = 47.69 ± 7.01 ms vs. 54.19 ± 6.21 ms (p < 0.001). The PWPT in the patients with AF recurrence was significantly longer than that in the non-recurrence patients: PWPT II = 50.48 ± 7.12 ms vs. 47.33 ± 6.21 ms (p < 0.001), PWPT V1 = 50.84 ± 7.05 ms vs. 47.19 ± 6.27 ms, (p < 0.001). The PWPT of the control group at the 12-month follow-up was similar to the baseline level: PWPT II = 54.32 ± 6.20 ms vs. 54.35 ± 6.12 ms (p > 0.05), PWPT V1 = 53.89 ± 6.01 ms vs. 54.31 ± 6.08 ms (p > 0.05).

Conclusion

The results showed that high-power short-duration PVI had a positive effect on PWPT, which is a predictor of PAF.
Literatur
1.
Zurück zum Zitat Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373–498CrossRefPubMed Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373–498CrossRefPubMed
2.
Zurück zum Zitat Kornej J, Börschel CS, Benjamin EJ et al (2020) Epidemiology of Atrial Fibrillation in the 21st. Century: Nov Methods New Insightscirc Res 127(1):4–20 Kornej J, Börschel CS, Benjamin EJ et al (2020) Epidemiology of Atrial Fibrillation in the 21st. Century: Nov Methods New Insightscirc Res 127(1):4–20
3.
Zurück zum Zitat Bayés de Luna A, Baranchuk A, Martínez-Sellés M (2017) Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift? Ann Noninvasive Electrocardiol 22(1):e12417CrossRefPubMed Bayés de Luna A, Baranchuk A, Martínez-Sellés M (2017) Anticoagulation in patients at high risk of stroke without documented atrial fibrillation. Time for a paradigm shift? Ann Noninvasive Electrocardiol 22(1):e12417CrossRefPubMed
4.
Zurück zum Zitat Chen LY, Soliman EZ (2019) P wave indices-advancing our understanding of atrial fibrillation-related cardiovascular outcomes. Front Cardiovasc Med 6:53CrossRefPubMedPubMedCentral Chen LY, Soliman EZ (2019) P wave indices-advancing our understanding of atrial fibrillation-related cardiovascular outcomes. Front Cardiovasc Med 6:53CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Çağdaş M, Karakoyun S, Rencüzoğulları İ et al (2020) P wave peak time; a novel electrocardiographic parameter in the assessment of coronary no-reflow. J Electrocardiol 50(5):584–590CrossRef Çağdaş M, Karakoyun S, Rencüzoğulları İ et al (2020) P wave peak time; a novel electrocardiographic parameter in the assessment of coronary no-reflow. J Electrocardiol 50(5):584–590CrossRef
6.
Zurück zum Zitat Bayam E, Yıldırım E, Kalçık M et al (2021) Relationship between P wave peak time and coronary artery disease severity in non-ST elevation acute coronary syndrome. Herz 46(2):188–194CrossRefPubMed Bayam E, Yıldırım E, Kalçık M et al (2021) Relationship between P wave peak time and coronary artery disease severity in non-ST elevation acute coronary syndrome. Herz 46(2):188–194CrossRefPubMed
7.
Zurück zum Zitat Chen LY, Ribeiro ALP, Platonov PG et al (2022) P Wave Parameters and Indices: A Critical Appraisal of Clinical Utility, Challenges, and Future Research‑A Consensus Document Endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrocardiology. Circ Arrhythm Electrophysiol 15(4):e10435PubMedPubMedCentral Chen LY, Ribeiro ALP, Platonov PG et al (2022) P Wave Parameters and Indices: A Critical Appraisal of Clinical Utility, Challenges, and Future Research‑A Consensus Document Endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrocardiology. Circ Arrhythm Electrophysiol 15(4):e10435PubMedPubMedCentral
8.
Zurück zum Zitat Öz A, Cinar T, Kızılto GC et al (2020) Novel electrocardiography parameter for paroxysmal atrial fibrillation in acute ischaemic stroke patients: P wave peak time. Postgrad Med J 96(1140):584–588CrossRefPubMed Öz A, Cinar T, Kızılto GC et al (2020) Novel electrocardiography parameter for paroxysmal atrial fibrillation in acute ischaemic stroke patients: P wave peak time. Postgrad Med J 96(1140):584–588CrossRefPubMed
9.
Zurück zum Zitat Yamaguchi T, Tsuchiya T, Fukui A et al (2018) Impact of the extent of low-voltage zone on outcomes after voltage-based catheter ablation for persistent atrial fibrillation. J Cardiol 72(5):427–433CrossRefPubMed Yamaguchi T, Tsuchiya T, Fukui A et al (2018) Impact of the extent of low-voltage zone on outcomes after voltage-based catheter ablation for persistent atrial fibrillation. J Cardiol 72(5):427–433CrossRefPubMed
10.
Zurück zum Zitat Masuda M, Fujita M, Iida O et al (2018) Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. Int J Cardiol 257:97–101CrossRefPubMed Masuda M, Fujita M, Iida O et al (2018) Left atrial low-voltage areas predict atrial fibrillation recurrence after catheter ablation in patients with paroxysmal atrial fibrillation. Int J Cardiol 257:97–101CrossRefPubMed
11.
Zurück zum Zitat Vlachos K, Efremidis M, Letsas KP et al (2017) Low-voltage areas detected by high-density electroanatomical mapping predict recurrence after ablation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 28:1393–1402CrossRefPubMed Vlachos K, Efremidis M, Letsas KP et al (2017) Low-voltage areas detected by high-density electroanatomical mapping predict recurrence after ablation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 28:1393–1402CrossRefPubMed
12.
Zurück zum Zitat Hohendanner F, Romero I, Blaschke F et al (2018) Extent and magnitude of low-voltage areas assessed by ultra-high-density electroanatomical mapping correlate with left atrial function. Int J Cardiol 272:108–112CrossRefPubMed Hohendanner F, Romero I, Blaschke F et al (2018) Extent and magnitude of low-voltage areas assessed by ultra-high-density electroanatomical mapping correlate with left atrial function. Int J Cardiol 272:108–112CrossRefPubMed
13.
Zurück zum Zitat Ibisoglu E, Boyraz B, Güneş ST et al (2021) Impact of surgical weight loss on novel P‑wave-related variables which are nominated as predictors of atrial arrhythmias. Pacing Clin Electrophysiol 44(9):1516–1522CrossRefPubMed Ibisoglu E, Boyraz B, Güneş ST et al (2021) Impact of surgical weight loss on novel P‑wave-related variables which are nominated as predictors of atrial arrhythmias. Pacing Clin Electrophysiol 44(9):1516–1522CrossRefPubMed
14.
Zurück zum Zitat Yıldız İ, Yildiz ÖP, Burak C et al (2020) P Wave Peak Time for Predicting an Increased Left Atrial Volume Index in Hemodialysis Patients. Med Princ Pract 29(3):262–269CrossRefPubMed Yıldız İ, Yildiz ÖP, Burak C et al (2020) P Wave Peak Time for Predicting an Increased Left Atrial Volume Index in Hemodialysis Patients. Med Princ Pract 29(3):262–269CrossRefPubMed
15.
Zurück zum Zitat Aslan B, Akyüz A, Işık F et al (2022) The effect of empagliflozin on P wave peak time and other P wave parameters in patients with diabetes mellitus. Pacing Clin Electrophysiol 45(3):323–329CrossRefPubMed Aslan B, Akyüz A, Işık F et al (2022) The effect of empagliflozin on P wave peak time and other P wave parameters in patients with diabetes mellitus. Pacing Clin Electrophysiol 45(3):323–329CrossRefPubMed
16.
Zurück zum Zitat Yıldırım E, Günay N, Bayam E et al (2019) Relationship between paroxysmal atrial fibrillation and a novel electrocardiographic parameter P wave peak time. J Electrocardiol 57:81–86CrossRefPubMed Yıldırım E, Günay N, Bayam E et al (2019) Relationship between paroxysmal atrial fibrillation and a novel electrocardiographic parameter P wave peak time. J Electrocardiol 57:81–86CrossRefPubMed
17.
Zurück zum Zitat Zengin A, Karataş MB, Çanga Y et al (2022) A novel electrocardiographic parameter for the prediction of atrial fibrillation after coronary artery bypass graft surgery “P wave peak time”. Ir J Med Sci 191(6):2579–2585CrossRefPubMed Zengin A, Karataş MB, Çanga Y et al (2022) A novel electrocardiographic parameter for the prediction of atrial fibrillation after coronary artery bypass graft surgery “P wave peak time”. Ir J Med Sci 191(6):2579–2585CrossRefPubMed
18.
Zurück zum Zitat Castrejón-Castrejón S, Martínez Cossiani M, Ortega Molina M et al (2020) Feasibility and safety of pulmonary vein isolation by high-power short-duration radiofrequency application: shortterm results of the POWER-FAST PILOT study. J Interv Card Electrophysiol 57(1):57–65CrossRefPubMed Castrejón-Castrejón S, Martínez Cossiani M, Ortega Molina M et al (2020) Feasibility and safety of pulmonary vein isolation by high-power short-duration radiofrequency application: shortterm results of the POWER-FAST PILOT study. J Interv Card Electrophysiol 57(1):57–65CrossRefPubMed
19.
Zurück zum Zitat Reddy VY, Grimaldi M, De Potter T et al (2019) Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC Clin Electrophysiol 5(7:778–786CrossRef Reddy VY, Grimaldi M, De Potter T et al (2019) Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC Clin Electrophysiol 5(7:778–786CrossRef
20.
Zurück zum Zitat Castrejón-Castrejón S, Martínez Cossiani M, Jáuregui-Abularach M et al (2023) Multicenter prospective comparison of conventional and high-power short duration radiofrequency application for pulmonary vein isolation: the high-power short-duration radiofrequency application for faster and safer pulmonary vein ablation (POWER FAST III) trial. J Interv Card Electrophysiol. https://doi.org/10.1007/s10840-023-01509-9CrossRefPubMed Castrejón-Castrejón S, Martínez Cossiani M, Jáuregui-Abularach M et al (2023) Multicenter prospective comparison of conventional and high-power short duration radiofrequency application for pulmonary vein isolation: the high-power short-duration radiofrequency application for faster and safer pulmonary vein ablation (POWER FAST III) trial. J Interv Card Electrophysiol. https://​doi.​org/​10.​1007/​s10840-023-01509-9CrossRefPubMed
21.
Zurück zum Zitat Yamasaki H, Aonuma K, Shinoda Y et al (2019) Initial Result of Antrum Pulmonary Vein Isolation Using the Radiofrequency Hot-Balloon CatheterWith Single-Shot Technique. JACC Clin Electrophysiol 5(3):354–363CrossRefPubMed Yamasaki H, Aonuma K, Shinoda Y et al (2019) Initial Result of Antrum Pulmonary Vein Isolation Using the Radiofrequency Hot-Balloon CatheterWith Single-Shot Technique. JACC Clin Electrophysiol 5(3):354–363CrossRefPubMed
22.
Zurück zum Zitat Maille B, Das M, Hussein A et al (2020) Reverse electrical and structural remodeling of the left atrium occurs early after pulmonary vein isolation for persistent atrial fibrillation. J Interv Card Electrophysiol 58(1):9–19CrossRefPubMed Maille B, Das M, Hussein A et al (2020) Reverse electrical and structural remodeling of the left atrium occurs early after pulmonary vein isolation for persistent atrial fibrillation. J Interv Card Electrophysiol 58(1):9–19CrossRefPubMed
23.
Zurück zum Zitat Soulat-Dufour L, Lang S, Addetia K et al (2022) Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation. J Am Coll Cardiol 79(10):951–961CrossRefPubMed Soulat-Dufour L, Lang S, Addetia K et al (2022) Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation. J Am Coll Cardiol 79(10):951–961CrossRefPubMed
24.
Zurück zum Zitat Masuda M, Asai M, Iida O et al (2022) Low-Voltage-Area Ablation in Paroxysmal Atrial Fibrillation-Extended Follow-up Results of the VOLCANO Trial. Circ J 86(2):245–252CrossRefPubMed Masuda M, Asai M, Iida O et al (2022) Low-Voltage-Area Ablation in Paroxysmal Atrial Fibrillation-Extended Follow-up Results of the VOLCANO Trial. Circ J 86(2):245–252CrossRefPubMed
Metadaten
Titel
The effect of high-power short-duration pulmonary vein isolation on PWPT—a predictor of paroxysmal atrial fibrillation
verfasst von
Meng Wang
Xiaochen Wang
Feng Gao
Pei Bao
Zheng Huang
Publikationsdatum
25.07.2023
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 1/2024
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-023-05198-y

Weitere Artikel der Ausgabe 1/2024

Herz 1/2024 Zur Ausgabe

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.